March 10 ,2026
The Center for Biotechnology is looking to bring on board a Venture Associate. The Venture Associate will work to source and select high-quality, founder-led companies, drive founder progress, and support execution...
Learn MoreThe Center for Biotechnology was thrilled to help Stony Brook University’s Office for Research and Innovation (OR&I) organize their second Wolf Den event on February 12, which featured three CFB Affiliated bi...
Learn MoreIn early February, we welcomed leadership from Empire State Development (ESD), including its Division of Science, Technology and Innovation (NYSTAR) and New York Ventures, for a two-day visit focused on applied res...
Learn MoreThe Redesignation brings $10 million in funding to drive innovation, company formation, and economic growth. The Center for Biotechnology (CFB) has announced its re-designated as a Center for Advanced Technology (CAT) by Empire State Development‘s Division of Science, Technology and …
Learn MoreGovernor Kathy Hochul has unveiled plans for New York BioGenesis Park, a groundbreaking $430 million Cell and Gene Therapy (CGT) Innovation Hub in Nassau County, Long Island. To be developed by The Albanese Organization, Inc., this state-of-the-art facility would catalyze …
Learn MoreKara Cannon, a member of the Center for Biotechnology, NYS Center for Advanced Technology’s Strategic Advisory Board, has been appointed Executive Director of the Tesla Science Center at Wardenclyffe (TSCW). Located on Long Island at the site of Nikola Tesla’s …
Learn MoreDr. Yusuf Hannun and his team at Stony Brook Medicine Cancer Center have been awarded a competitive $11 million NIH Program Project Grant to advance groundbreaking research on sphingolipids in cancer biology and therapy. This is a major milestone for …
Learn MoreFuzeHub is accepting applications for its ninth New York State Commercialization Competition. Startups can compete for awards up to $150K to advance the commercialization of their innovative products or technologies.
Learn MoreEnvisagenics, supported by the Center for Biotechnology at Stony Brook University, is a pioneering biotech company that has been applying AI to drug target discovery for over a decade. In drug development, targets are molecular structures (often proteins) where drugs …
Learn MoreIf you’re thinking about submitting a proposal for the September NIH SBIR/STTR deadline, don’t miss this free virtual workshop series!
Learn More